Harvard Bioscience targets 3% to 5% full-year 2026 revenue growth as CMT and China mix shifts gross margin to 57% to 59%

Kamada Q2 2026 Earnings Preview

2026/08/11

Social Security expands list of conditions to 314 illnesses for faster disability claims

2026/08/11

Nvidia just soothed a major market fear about AI, analysts say

2026/08/11

iRhythm edges lower amid Spruce Point short comments

2026/08/11